Letter to medicines and medical products suppliers: 3 August 2020

Added message that DHSC’s requests of industry set out in this letter remain valid and current, after the trade and cooperation agreement reached between the EU and the UK.

Based on wider consultation and feedback, we have updated the letter to include mention of the cross-government reasonable worst case scenario (RWCS) being used for planning purposes and some of the fundamentals of those assumptions, including the time-limited nature of any potential disruption.

First published.